A nationwide French cohort study published in The Lancet Public Health demonstrates that opioid agonist treatment substantially reduces mortality risk among people with opioid use disorder in primary care, with buprenorphine showing particularly marked benefits. The findings validate primary care decentralisation of OAT delivery. — Photo by MART PRODUCTION on Pexels (Pexels License)
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
